TP53 and cancer: Based on the aforementioned Mouse Embryonic Fibroblasts (MEF) model, it is clear that genomic destabilization is associated with mutagenesis and the resultant clonal evolution of cells with mutations in cancer-driver genes (e.g., the ARF/p53 module) [7].